Our Company, Himalaya Nutravedics India Limited (the “Company”), is engaged in the manufacture, marketing and distribution of Ayurvedic and Nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and Nutraceutical companies. Our Company manufactures a diversified portfolio comprising classical (Shastric) Ayurvedic formulations, which are based on compositions and processes described in traditional Ayurvedic texts, proprietary Ayurvedic formulations and Nutraceutical products across multiple dosage forms, including soft gelatin capsules, hard gelatin capsules, tablets, Liquid orals, Medicated oils. The Ayurvedic formulations and nutraceuticals industry is a specialised segment within India’s pharmaceutical and wellness ecosystem, covering the manufacture of Ayurvedic, herbal, and dietary supplements under NIC divisions for pharmaceuticals, AYUSH products, and food preparations.
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 0% | -- |
| Non-Institutional Investors (NIIs) | 0% | -- |
| Retail Individual Investors (RIIs) | 100% | -- |
Himalaya Nutravedics’s total income 0.00 by 0.00% and total expenses 3,496.24 by 94.18%, resulting in an EBITDA 815.79 by 172.71% and a profit after tax (PAT) 0.00 by 0.00% between March 31, 2025 and March 31, 2026.
3,496.2431 March 2026 | 1,800.5531 March 2025 | 1,34931 March 2024 |
815.7931 March 2026 | 299.1431 March 2025 | 93.8931 March 2024 |
3,496.24
3,147
2,797
2,447
2,098
1,748
1,398
1,049
699
350
0.00
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| -- | -- | -- |
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 0 shares (aggregating up to To be announced) |
| Fresh Issue | 0 shares (aggregating up to To be announced) |
| Offer for Sale | 0 shares of ₹10 (aggregating up to To be announced) |
| Issue Type | Book building |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 95.14 shares |
| Post-Issue Shareholding | 0 shares |
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Himalaya Nutravedics ipo has been designed to ensure broad participation while maintaining optimal price discovery.
Plot No 101 / A Phase- I I I Industrial Development Park Hyderabad
| Book Running Lead Manager(s) |
|---|
| Nirbhay Capital Services Pvt Ltd |